Cargando…

The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK

The first SARS-CoV-2 variant of concern (VOC) to be designated was lineage B.1.1.7, later labelled by the World Health Organization as Alpha. Originating in early autumn but discovered in December 2020, it spread rapidly and caused large waves of infections worldwide. The Alpha variant is notable fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Verity, Du Plessis, Louis, Peacock, Thomas P, Aggarwal, Dinesh, Colquhoun, Rachel, Carabelli, Alesandro M, Ellaby, Nicholas, Gallagher, Eileen, Groves, Natalie, Jackson, Ben, McCrone, J T, O’Toole, Áine, Price, Anna, Sanderson, Theo, Scher, Emily, Southgate, Joel, Volz, Erik, Barclay, Wendy S, Barrett, Jeffrey C, Chand, Meera, Connor, Thomas, Goodfellow, Ian, Gupta, Ravindra K, Harrison, Ewan M, Loman, Nicholas, Myers, Richard, Robertson, David L, Pybus, Oliver G, Rambaut, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752794/
https://www.ncbi.nlm.nih.gov/pubmed/36533153
http://dx.doi.org/10.1093/ve/veac080
_version_ 1784850815158059008
author Hill, Verity
Du Plessis, Louis
Peacock, Thomas P
Aggarwal, Dinesh
Colquhoun, Rachel
Carabelli, Alesandro M
Ellaby, Nicholas
Gallagher, Eileen
Groves, Natalie
Jackson, Ben
McCrone, J T
O’Toole, Áine
Price, Anna
Sanderson, Theo
Scher, Emily
Southgate, Joel
Volz, Erik
Barclay, Wendy S
Barrett, Jeffrey C
Chand, Meera
Connor, Thomas
Goodfellow, Ian
Gupta, Ravindra K
Harrison, Ewan M
Loman, Nicholas
Myers, Richard
Robertson, David L
Pybus, Oliver G
Rambaut, Andrew
author_facet Hill, Verity
Du Plessis, Louis
Peacock, Thomas P
Aggarwal, Dinesh
Colquhoun, Rachel
Carabelli, Alesandro M
Ellaby, Nicholas
Gallagher, Eileen
Groves, Natalie
Jackson, Ben
McCrone, J T
O’Toole, Áine
Price, Anna
Sanderson, Theo
Scher, Emily
Southgate, Joel
Volz, Erik
Barclay, Wendy S
Barrett, Jeffrey C
Chand, Meera
Connor, Thomas
Goodfellow, Ian
Gupta, Ravindra K
Harrison, Ewan M
Loman, Nicholas
Myers, Richard
Robertson, David L
Pybus, Oliver G
Rambaut, Andrew
author_sort Hill, Verity
collection PubMed
description The first SARS-CoV-2 variant of concern (VOC) to be designated was lineage B.1.1.7, later labelled by the World Health Organization as Alpha. Originating in early autumn but discovered in December 2020, it spread rapidly and caused large waves of infections worldwide. The Alpha variant is notable for being defined by a long ancestral phylogenetic branch with an increased evolutionary rate, along which only two sequences have been sampled. Alpha genomes comprise a well-supported monophyletic clade within which the evolutionary rate is typical of SARS-CoV-2. The Alpha epidemic continued to grow despite the continued restrictions on social mixing across the UK and the imposition of new restrictions, in particular, the English national lockdown in November 2020. While these interventions succeeded in reducing the absolute number of cases, the impact of these non-pharmaceutical interventions was predominantly to drive the decline of the SARS-CoV-2 lineages that preceded Alpha. We investigate the only two sampled sequences that fall on the branch ancestral to Alpha. We find that one is likely to be a true intermediate sequence, providing information about the order of mutational events that led to Alpha. We explore alternate hypotheses that can explain how Alpha acquired a large number of mutations yet remained largely unobserved in a region of high genomic surveillance: an under-sampled geographical location, a non-human animal population, or a chronically infected individual. We conclude that the latter provides the best explanation of the observed behaviour and dynamics of the variant, although the individual need not be immunocompromised, as persistently infected immunocompetent hosts also display a higher within-host rate of evolution. Finally, we compare the ancestral branches and mutation profiles of other VOCs and find that Delta appears to be an outlier both in terms of the genomic locations of its defining mutations and a lack of the rapid evolutionary rate on its ancestral branch. As new variants, such as Omicron, continue to evolve (potentially through similar mechanisms), it remains important to investigate the origins of other variants to identify ways to potentially disrupt their evolution and emergence.
format Online
Article
Text
id pubmed-9752794
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97527942022-12-16 The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK Hill, Verity Du Plessis, Louis Peacock, Thomas P Aggarwal, Dinesh Colquhoun, Rachel Carabelli, Alesandro M Ellaby, Nicholas Gallagher, Eileen Groves, Natalie Jackson, Ben McCrone, J T O’Toole, Áine Price, Anna Sanderson, Theo Scher, Emily Southgate, Joel Volz, Erik Barclay, Wendy S Barrett, Jeffrey C Chand, Meera Connor, Thomas Goodfellow, Ian Gupta, Ravindra K Harrison, Ewan M Loman, Nicholas Myers, Richard Robertson, David L Pybus, Oliver G Rambaut, Andrew Virus Evol Research Article The first SARS-CoV-2 variant of concern (VOC) to be designated was lineage B.1.1.7, later labelled by the World Health Organization as Alpha. Originating in early autumn but discovered in December 2020, it spread rapidly and caused large waves of infections worldwide. The Alpha variant is notable for being defined by a long ancestral phylogenetic branch with an increased evolutionary rate, along which only two sequences have been sampled. Alpha genomes comprise a well-supported monophyletic clade within which the evolutionary rate is typical of SARS-CoV-2. The Alpha epidemic continued to grow despite the continued restrictions on social mixing across the UK and the imposition of new restrictions, in particular, the English national lockdown in November 2020. While these interventions succeeded in reducing the absolute number of cases, the impact of these non-pharmaceutical interventions was predominantly to drive the decline of the SARS-CoV-2 lineages that preceded Alpha. We investigate the only two sampled sequences that fall on the branch ancestral to Alpha. We find that one is likely to be a true intermediate sequence, providing information about the order of mutational events that led to Alpha. We explore alternate hypotheses that can explain how Alpha acquired a large number of mutations yet remained largely unobserved in a region of high genomic surveillance: an under-sampled geographical location, a non-human animal population, or a chronically infected individual. We conclude that the latter provides the best explanation of the observed behaviour and dynamics of the variant, although the individual need not be immunocompromised, as persistently infected immunocompetent hosts also display a higher within-host rate of evolution. Finally, we compare the ancestral branches and mutation profiles of other VOCs and find that Delta appears to be an outlier both in terms of the genomic locations of its defining mutations and a lack of the rapid evolutionary rate on its ancestral branch. As new variants, such as Omicron, continue to evolve (potentially through similar mechanisms), it remains important to investigate the origins of other variants to identify ways to potentially disrupt their evolution and emergence. Oxford University Press 2022-08-26 /pmc/articles/PMC9752794/ /pubmed/36533153 http://dx.doi.org/10.1093/ve/veac080 Text en © The Author(s) 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Research Article
Hill, Verity
Du Plessis, Louis
Peacock, Thomas P
Aggarwal, Dinesh
Colquhoun, Rachel
Carabelli, Alesandro M
Ellaby, Nicholas
Gallagher, Eileen
Groves, Natalie
Jackson, Ben
McCrone, J T
O’Toole, Áine
Price, Anna
Sanderson, Theo
Scher, Emily
Southgate, Joel
Volz, Erik
Barclay, Wendy S
Barrett, Jeffrey C
Chand, Meera
Connor, Thomas
Goodfellow, Ian
Gupta, Ravindra K
Harrison, Ewan M
Loman, Nicholas
Myers, Richard
Robertson, David L
Pybus, Oliver G
Rambaut, Andrew
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
title The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
title_full The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
title_fullStr The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
title_full_unstemmed The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
title_short The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
title_sort origins and molecular evolution of sars-cov-2 lineage b.1.1.7 in the uk
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752794/
https://www.ncbi.nlm.nih.gov/pubmed/36533153
http://dx.doi.org/10.1093/ve/veac080
work_keys_str_mv AT hillverity theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT duplessislouis theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT peacockthomasp theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT aggarwaldinesh theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT colquhounrachel theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT carabellialesandrom theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT ellabynicholas theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT gallaghereileen theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT grovesnatalie theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT jacksonben theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT mccronejt theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT otooleaine theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT priceanna theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT sandersontheo theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT scheremily theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT southgatejoel theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT volzerik theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT barclaywendys theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT barrettjeffreyc theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT chandmeera theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT connorthomas theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT goodfellowian theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT guptaravindrak theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT harrisonewanm theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT lomannicholas theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT myersrichard theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT robertsondavidl theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT pybusoliverg theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT rambautandrew theoriginsandmolecularevolutionofsarscov2lineageb117intheuk
AT hillverity originsandmolecularevolutionofsarscov2lineageb117intheuk
AT duplessislouis originsandmolecularevolutionofsarscov2lineageb117intheuk
AT peacockthomasp originsandmolecularevolutionofsarscov2lineageb117intheuk
AT aggarwaldinesh originsandmolecularevolutionofsarscov2lineageb117intheuk
AT colquhounrachel originsandmolecularevolutionofsarscov2lineageb117intheuk
AT carabellialesandrom originsandmolecularevolutionofsarscov2lineageb117intheuk
AT ellabynicholas originsandmolecularevolutionofsarscov2lineageb117intheuk
AT gallaghereileen originsandmolecularevolutionofsarscov2lineageb117intheuk
AT grovesnatalie originsandmolecularevolutionofsarscov2lineageb117intheuk
AT jacksonben originsandmolecularevolutionofsarscov2lineageb117intheuk
AT mccronejt originsandmolecularevolutionofsarscov2lineageb117intheuk
AT otooleaine originsandmolecularevolutionofsarscov2lineageb117intheuk
AT priceanna originsandmolecularevolutionofsarscov2lineageb117intheuk
AT sandersontheo originsandmolecularevolutionofsarscov2lineageb117intheuk
AT scheremily originsandmolecularevolutionofsarscov2lineageb117intheuk
AT southgatejoel originsandmolecularevolutionofsarscov2lineageb117intheuk
AT volzerik originsandmolecularevolutionofsarscov2lineageb117intheuk
AT barclaywendys originsandmolecularevolutionofsarscov2lineageb117intheuk
AT barrettjeffreyc originsandmolecularevolutionofsarscov2lineageb117intheuk
AT chandmeera originsandmolecularevolutionofsarscov2lineageb117intheuk
AT connorthomas originsandmolecularevolutionofsarscov2lineageb117intheuk
AT goodfellowian originsandmolecularevolutionofsarscov2lineageb117intheuk
AT guptaravindrak originsandmolecularevolutionofsarscov2lineageb117intheuk
AT harrisonewanm originsandmolecularevolutionofsarscov2lineageb117intheuk
AT lomannicholas originsandmolecularevolutionofsarscov2lineageb117intheuk
AT myersrichard originsandmolecularevolutionofsarscov2lineageb117intheuk
AT robertsondavidl originsandmolecularevolutionofsarscov2lineageb117intheuk
AT pybusoliverg originsandmolecularevolutionofsarscov2lineageb117intheuk
AT rambautandrew originsandmolecularevolutionofsarscov2lineageb117intheuk